These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38395995)

  • 1. Modulation of cAMP/cGMP signaling as prevention of congenital heart defects in Pde2A deficient embryos: a matter of oxidative stress.
    Cardarelli S; Biglietto M; Orsini T; Fustaino V; Monaco L; de Oliveira do Rêgo AG; Liccardo F; Masciarelli S; Fazi F; Naro F; De Angelis L; Pellegrini M
    Cell Death Dis; 2024 Feb; 15(2):169. PubMed ID: 38395995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of phosphodiesterase 2A in mouse congenital heart defects.
    Assenza MR; Barbagallo F; Barrios F; Cornacchione M; Campolo F; Vivarelli E; Gianfrilli D; Auletta L; Soricelli A; Isidori AM; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2018 May; 114(6):830-845. PubMed ID: 29409032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphodiesterase 2A controls lymphatic junctional maturation via cGMP-dependent notch signaling.
    Carlantoni C; Liekfeld LMH; Hemkemeyer SA; Schreier D; Saygi C; Kurelic R; Cardarelli S; Kalucka J; Schulte C; Beerens M; Mailer RK; Schäffer TE; Naro F; Pellegrini M; Nikolaev VO; Renné T; Frye M
    Dev Cell; 2024 Feb; 59(3):308-325.e11. PubMed ID: 38159569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.
    Rentsendorj O; D'Alessio FR; Pearse DB
    J Leukoc Biol; 2014 Nov; 96(5):907-15. PubMed ID: 25063878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis.
    Barbagallo F; Rotilio V; Assenza MR; Aguanno S; Orsini T; Putti S; Isidori AM; Lenzi A; Naro F; De Angelis L; Pellegrini M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor.
    de Oliveira SK; Hoffmeister M; Gambaryan S; Müller-Esterl W; Guimaraes JA; Smolenski AP
    J Biol Chem; 2007 May; 282(18):13656-63. PubMed ID: 17329248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present).
    Trabanco AA; Buijnsters P; Rombouts FJ
    Expert Opin Ther Pat; 2016 Aug; 26(8):933-46. PubMed ID: 27321640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of phosphodiesterase 2A in the submandibular gland of mice.
    Adthapanyawanich K; Nakata H; Iseki S
    Arch Oral Biol; 2018 Jun; 90():91-99. PubMed ID: 29597062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons.
    Lin DT; Fretier P; Jiang C; Vincent SR
    Synapse; 2010 Jun; 64(6):460-6. PubMed ID: 20175220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of lead BAY60-7550 analogues as potential inhibitors that utilize the hydrophobic groove in PDE2A: a molecular dynamics simulation study.
    Kumar J; Umar T; Kausar T; Mobashir M; Nayeem SM; Hoda N
    J Mol Model; 2017 Jan; 23(1):7. PubMed ID: 27966018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of lung phosphodiesterase 2A attenuates alveolar inflammation and protein leak in a two-hit mouse model of acute lung injury.
    Rentsendorj O; Damarla M; Aggarwal NR; Choi JY; Johnston L; D'Alessio FR; Crow MT; Pearse DB
    Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L161-70. PubMed ID: 21571906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 Knock-Out in Primary Neonatal and Adult Cardiomyocytes Reveals Distinct cAMP Dynamics Regulation by Various PDE2A and PDE3A Isoforms.
    Skryabin EB; De Jong KA; Subramanian H; Bork NI; Froese A; Skryabin BV; Nikolaev VO
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Concentration Oxygen/Ozone Treatment Attenuated Radiculitis and Mechanical Allodynia via PDE2A-cAMP/cGMP-NF-
    Wang J; Wu M; Lin X; Li Y; Fu Z
    Pain Res Manag; 2018; 2018():5192814. PubMed ID: 30651902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
    Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
    Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel PDE2A reporter cell line: characterization of the cellular activity of PDE inhibitors.
    Wunder F; Gnoth MJ; Geerts A; Barufe D
    Mol Pharm; 2009; 6(1):326-36. PubMed ID: 19049345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Inhibition Modality for Phosphodiesterase 2A.
    Nakashima K; Matsui H
    SLAS Discov; 2020 Jun; 25(5):498-505. PubMed ID: 32343157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity.
    Liu K; Li D; Hao G; McCaffary D; Neely O; Woodward L; Ioannides D; Lu CJ; Brescia M; Zaccolo M; Tandri H; Ajijola OA; Ardell JL; Shivkumar K; Paterson DJ
    JCI Insight; 2018 May; 3(9):. PubMed ID: 29720569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.
    Chen L; Cui S; Yu H; Li G; Liu N; Wu Q; Zhang HT; O'Donnell JM; Wang G; Xu Y
    J Psychopharmacol; 2019 May; 33(5):568-576. PubMed ID: 30835157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dorsal root ganglion axon bifurcation tolerates increased cyclic GMP levels: the role of phosphodiesterase 2A and scavenger receptor Npr3.
    Schmidt H; Peters S; Frank K; Wen L; Feil R; Rathjen FG
    Eur J Neurosci; 2016 Dec; 44(12):2991-3000. PubMed ID: 27740716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.